Alembic Stock/Share Prices, Buy and Sell Alembic BSE Stocks

Alembic Ltd NSE / BSE
Pharmaceuticals, Mid Cap

Invest

19 Oct 2018 | 03:59 PM

40.50

-0.70 (-1.70%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

3.58%

Return (1Y)

Beaten S&P BSE Healthcare by 0.66%
More Volatile

3.05%

Standard Deviation (1Y)

Higher than S&P BSE Healthcare by 1.95%
Consistent Performer

7/12

Months

beaten S&P BSE Healthcare
AxisDirect View

No View

52 Week High-Low

News & Announcements

Board of Alembic accords in-principle approval for scheme of arrangement
39 days ago

Board of Alembic accords in-principle approval for scheme of arrangement

11 - Sep - 2018 12:00 AM | 39 days ago

The Board of Alembic at its meeting held on 11 September 2018 has inter alia considered and accorded 'in-principle' approval to the proposal to demerge the Identified Real Estate Undertaking of the Company into Shreno, an unlisted public limited company, to be implemented by way of a Scheme of Arrangement.
The Identified Real Estate Undertaking proposed to be demerged would comprise of:
i) A premium residential real estate project of Alembic;
ii) Interest in real estate business held through investment in Shreno; and
iii) Project Management Consultancy ('PMC') business, services of which are provided by the Company to Shreno.
Powered by Capital Market - Live News
Alembic standalone net profit rises 106.27% in the June 2018 quarter
75 days ago

Alembic standalone net profit rises 106.27% in the June 2018 quarter

07 - Aug - 2018 12:00 AM | 75 days ago

Net profit of Alembic rose 106.27% to Rs 6.91 crore in the quarter ended June 2018 as against Rs 3.35 crore during the previous quarter ended June 2017. Sales rose 50.35% to Rs 44.52 crore in the quarter ended June 2018 as against Rs 29.61 crore during the previous quarter ended June 2017.
Particulars Quarter Ended
Jun. 2018 Jun. 2017 % Var.
Sales 44.52 29.61 50
OPM % 18.53 6.01 -
PBDT 9.49 5.59 70
PBT 8.85 4.36 103
NP 6.91 3.35 106
Powered by Capital Market - Live News
Alembic schedules board meeting
82 days ago

Alembic schedules board meeting

31 - Jul - 2018 12:00 AM | 82 days ago

Alembic will hold a meeting of the Board of Directors of the Company on 7 August 2018.
Powered by Capital Market - Live News
Alembic to hold AGM
108 days ago

Alembic to hold AGM

05 - Jul - 2018 12:00 AM | 108 days ago

Alembic announced that the Annual General Meeting (AGM) of the company will be held on 7 August 2018.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Alembic Ltd has decreased by -8.31% since past 3 Months
MF shareholding in Alembic Ltd has increased by 7.1% since past 3 Months
FII shareholding in Alembic Ltd has decreased by -29.81% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Jun. 2018	Jun. 2017	% Var.
Sales	44.52	29.61	50
OPM %	18.53	6.01	-
PBDT	9.49	5.59	70
PBT	8.85	4.36	103
NP	6.91	3.35	106

General Notifications

My Notifications

Research Notifications

Alembic Ltd NSE / BSE Pharmaceuticals, Mid Cap

40.50 -0.70 (-1.70%)

News & Announcements

Price vs Volume

Stock Trivia

Alembic Ltd NSE / BSE
Pharmaceuticals, Mid Cap

40.50

-0.70 (-1.70%)